ALT
Price
$5.71
Change
-$0.06 (-1.04%)
Updated
May 23 closing price
Capitalization
467.99M
75 days until earnings call
XNCR
Price
$7.57
Change
-$0.12 (-1.56%)
Updated
May 23 closing price
Capitalization
547.3M
67 days until earnings call
Interact to see
Advertisement

ALT vs XNCR

Header iconALT vs XNCR Comparison
Open Charts ALT vs XNCRBanner chart's image
Altimmune
Price$5.71
Change-$0.06 (-1.04%)
Volume$1.65M
Capitalization467.99M
Xencor
Price$7.57
Change-$0.12 (-1.56%)
Volume$841.1K
Capitalization547.3M
ALT vs XNCR Comparison Chart
Loading...
ALT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XNCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALT vs. XNCR commentary
May 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALT is a StrongBuy and XNCR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
May 25, 2025
Stock price -- (ALT: $5.77 vs. XNCR: $7.69)
Brand notoriety: ALT and XNCR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALT: 66% vs. XNCR: 100%
Market capitalization -- ALT: $467.99M vs. XNCR: $547.3M
ALT [@Biotechnology] is valued at $467.99M. XNCR’s [@Biotechnology] market capitalization is $547.3M. The market cap for tickers in the [@Biotechnology] industry ranges from $307B to $0. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALT’s FA Score shows that 0 FA rating(s) are green whileXNCR’s FA Score has 1 green FA rating(s).

  • ALT’s FA Score: 0 green, 5 red.
  • XNCR’s FA Score: 1 green, 4 red.
According to our system of comparison, XNCR is a better buy in the long-term than ALT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALT’s TA Score shows that 4 TA indicator(s) are bullish while XNCR’s TA Score has 4 bullish TA indicator(s).

  • ALT’s TA Score: 4 bullish, 5 bearish.
  • XNCR’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, XNCR is a better buy in the short-term than ALT.

Price Growth

ALT (@Biotechnology) experienced а -0.17% price change this week, while XNCR (@Biotechnology) price change was -6.22% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.07%. For the same industry, the average monthly price growth was +3.12%, and the average quarterly price growth was -3.91%.

Reported Earning Dates

ALT is expected to report earnings on Aug 07, 2025.

XNCR is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Biotechnology (+1.07% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
XNCR($547M) has a higher market cap than ALT($468M). ALT YTD gains are higher at: -19.972 vs. XNCR (-66.536). ALT has higher annual earnings (EBITDA): -94.81M vs. XNCR (-186.17M). XNCR has more cash in the bank: 498M vs. ALT (132M). ALT has less debt than XNCR: ALT (1.68M) vs XNCR (232M). XNCR has higher revenues than ALT: XNCR (110M) vs ALT (20K).
ALTXNCRALT / XNCR
Capitalization468M547M86%
EBITDA-94.81M-186.17M51%
Gain YTD-19.972-66.53630%
P/E RatioN/AN/A-
Revenue20K110M0%
Total Cash132M498M27%
Total Debt1.68M232M1%
FUNDAMENTALS RATINGS
ALT vs XNCR: Fundamental Ratings
ALT
XNCR
OUTLOOK RATING
1..100
614
VALUATION
overvalued / fair valued / undervalued
1..100
97
Overvalued
79
Overvalued
PROFIT vs RISK RATING
1..100
88100
SMR RATING
1..100
9797
PRICE GROWTH RATING
1..100
6096
P/E GROWTH RATING
1..100
1004
SEASONALITY SCORE
1..100
75n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

XNCR's Valuation (79) in the Biotechnology industry is in the same range as ALT (97) in the Miscellaneous Commercial Services industry. This means that XNCR’s stock grew similarly to ALT’s over the last 12 months.

ALT's Profit vs Risk Rating (88) in the Miscellaneous Commercial Services industry is in the same range as XNCR (100) in the Biotechnology industry. This means that ALT’s stock grew similarly to XNCR’s over the last 12 months.

ALT's SMR Rating (97) in the Miscellaneous Commercial Services industry is in the same range as XNCR (97) in the Biotechnology industry. This means that ALT’s stock grew similarly to XNCR’s over the last 12 months.

ALT's Price Growth Rating (60) in the Miscellaneous Commercial Services industry is somewhat better than the same rating for XNCR (96) in the Biotechnology industry. This means that ALT’s stock grew somewhat faster than XNCR’s over the last 12 months.

XNCR's P/E Growth Rating (4) in the Biotechnology industry is significantly better than the same rating for ALT (100) in the Miscellaneous Commercial Services industry. This means that XNCR’s stock grew significantly faster than ALT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALTXNCR
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
79%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
88%
Bullish Trend 3 days ago
73%
Momentum
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
82%
MACD
ODDS (%)
N/A
Bearish Trend 3 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
86%
Bearish Trend 3 days ago
84%
Advances
ODDS (%)
Bullish Trend 17 days ago
83%
Bullish Trend 10 days ago
71%
Declines
ODDS (%)
Bearish Trend 6 days ago
89%
Bearish Trend 18 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
71%
Bullish Trend 3 days ago
69%
Aroon
ODDS (%)
Bullish Trend 3 days ago
89%
Bearish Trend 4 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
ALT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XNCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME30.862.81
+10.02%
GameStop Corp
TSLA341.046.42
+1.92%
Tesla
BTC.X111673.2800001995.203100
+1.82%
Bitcoin cryptocurrency
SPY583.090.23
+0.04%
SPDR® S&P 500® ETF
AAPL201.36-0.73
-0.36%
Apple

ALT and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALT has been loosely correlated with CRNX. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if ALT jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALT
1D Price
Change %
ALT100%
+3.22%
CRNX - ALT
50%
Loosely correlated
+0.53%
XNCR - ALT
47%
Loosely correlated
+2.26%
COGT - ALT
46%
Loosely correlated
-0.60%
CLDX - ALT
46%
Loosely correlated
N/A
VKTX - ALT
46%
Loosely correlated
+1.76%
More

XNCR and

Correlation & Price change

A.I.dvisor indicates that over the last year, XNCR has been loosely correlated with RCKT. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if XNCR jumps, then RCKT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XNCR
1D Price
Change %
XNCR100%
+2.26%
RCKT - XNCR
59%
Loosely correlated
N/A
CRNX - XNCR
58%
Loosely correlated
+0.53%
ERAS - XNCR
57%
Loosely correlated
-0.82%
ACLX - XNCR
57%
Loosely correlated
-0.50%
BCYC - XNCR
54%
Loosely correlated
+0.62%
More